Efficient and Rapid Purification of E. coli Expressed
Toxin Recombinant Protein Fragments
Please join us for this free, live Ask the Expert webcast.Just fill out the form below to register.
Presenter:
Andrew Lees, PhDFounder and Scientific Director
Fina Biosolutions, LLC
Andrew Lees is the founder and scientific director of Fina Biosolutions LLC, in Rockville, MD. He is an expert in the chemistry of conjugate vaccines with over 25 patents to his name and an author on over 70 peer-reviewed articles. Conjugation chemistry developed by Dr. Lees is used by GlaxoSmithKline, the Serum Institute of India, the Chengdu Institute of Biological Products and others in their Streptococcus pneumoniae and meningococcal conjugate vaccines. Much of his career has focused on helping to make conjugate vaccines more affordable.
Dr. Lees is also an Associate Professor at the Center for Vaccine Development at the University of Maryland School of Medicine. Lees holds a BS in Chemistry from Harvey Mudd College and a PhD in Biophysics from The Johns Hopkins University. He is a Johns Hopkins Distinguished Alumnus.
Dr. Lees is also an Associate Professor at the Center for Vaccine Development at the University of Maryland School of Medicine. Lees holds a BS in Chemistry from Harvey Mudd College and a PhD in Biophysics from The Johns Hopkins University. He is a Johns Hopkins Distinguished Alumnus.
